Search results: Sage Journals

Restricted accessResearch articleFirst published July, 2019

Correlation of Physician-Assessed Psoriasis Area and Severity Index Scores With Patient-Reported Psoriasis Symptoms and Signs Diary Scores Among Patients With Moderate-to-Severe Psoriasis: Results From VOYAGE 1 and VOYAGE 2 Studies

Kenneth B. Gordon, Chenglong Han, Shu Li [...]

Journal of Psoriasis and Psoriatic Arthritis®

Restricted accessResearch articleFirst published December, 2016

Review of Available and Investigational Biologics and Non-Biologic Small Molecules for the Treatment of Plaque Psoriasis

Yasmin Amir, Mark G. Lebwohl

Journal of Psoriasis and Psoriatic Arthritis®

Open accessResearch articleFirst published 2024

Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea

Byung Soo Kim, Dong Hyun Kim, Bong Seok Shin [...]

Sage Open Chronic Disease

Restricted accessResearch articleFirst published October, 2019

Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P

Kim Papp, Andrew Blauvelt, John Sullivan [...]

Journal of Psoriasis and Psoriatic Arthritis®

Restricted accessResearch articleFirst published November, 2020

Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis

Weiguang Xue, Paranjoy Saharia, Emma Gray [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessReview articleFirst published April, 2021

Speed of Psoriasis Treatment Response for Biologic Agents: A Review of Phase III Clinical Trials

Matthew C. Johnson, Courtney E. Heron, Rima I. Ghamrawi [...]

Journal of Psoriasis and Psoriatic Arthritis®

Free accessResearch articleFirst published July, 2010

Treatment of Psoriasis with Different Dosage Regimens of Etanercept: Preliminary Results from the TαRanta Plastic Study Group

N. Cassano, F. Loconsole, A. Miracapillo [...]

International Journal of Immunopathology and Pharmacology

Restricted accessResearch articleFirst published January, 2020

A Reevaluation of the Simplified Psoriasis Index (SPI) Using the Thai Language Version: A Study Examining the Validity,Reliability,and Interpretability of SPI When Used in Translation

Leena Chularojanamontri, Chanisada Wongpraparut, Waranaree Winayanuwattikun [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open accessResearch articleFirst published March, 2025

Real-World Effectiveness of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Canada

Mohannad Abu-Hilal, Jeff Cowger, Mohammed Bawazir [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessReview articleFirst published 2026

Safety and Efficacy of the Oral IL-23 Receptor Antagonist Icotrokinra for Plaque Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Mohammed R. Abdeldayem, Ahmed Elsherbeeny

Journal of Cutaneous Medicine and Surgery

Restricted accessResearch articleFirst published July, 2019

Correlation of Physician-Assessed Psoriasis Area and Severity Index Scores With Patient-Reported Psoriasis Symptoms and Signs Diary Scores Among Patients With Moderate-to-Severe Psoriasis: Results From VOYAGE 1 and VOYAGE 2 Studies

Kenneth B. Gordon, Chenglong Han, Shu Li [...]

Journal of Psoriasis and Psoriatic Arthritis®

Restricted accessResearch articleFirst published December, 2016

Review of Available and Investigational Biologics and Non-Biologic Small Molecules for the Treatment of Plaque Psoriasis

Yasmin Amir, Mark G. Lebwohl

Journal of Psoriasis and Psoriatic Arthritis®

Open accessResearch articleFirst published 2024

Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea

Byung Soo Kim, Dong Hyun Kim, Bong Seok Shin [...]

Sage Open Chronic Disease

Restricted accessResearch articleFirst published October, 2019

Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P

Kim Papp, Andrew Blauvelt, John Sullivan [...]

Journal of Psoriasis and Psoriatic Arthritis®

Restricted accessResearch articleFirst published November, 2020

Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis

Weiguang Xue, Paranjoy Saharia, Emma Gray [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessReview articleFirst published April, 2021

Speed of Psoriasis Treatment Response for Biologic Agents: A Review of Phase III Clinical Trials

Matthew C. Johnson, Courtney E. Heron, Rima I. Ghamrawi [...]

Journal of Psoriasis and Psoriatic Arthritis®

Free accessResearch articleFirst published July, 2010

Treatment of Psoriasis with Different Dosage Regimens of Etanercept: Preliminary Results from the TαRanta Plastic Study Group

N. Cassano, F. Loconsole, A. Miracapillo [...]

International Journal of Immunopathology and Pharmacology

Restricted accessResearch articleFirst published January, 2020

A Reevaluation of the Simplified Psoriasis Index (SPI) Using the Thai Language Version: A Study Examining the Validity,Reliability,and Interpretability of SPI When Used in Translation

Leena Chularojanamontri, Chanisada Wongpraparut, Waranaree Winayanuwattikun [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open accessResearch articleFirst published March, 2025

Real-World Effectiveness of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Canada

Mohannad Abu-Hilal, Jeff Cowger, Mohammed Bawazir [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessReview articleFirst published 2026

Safety and Efficacy of the Oral IL-23 Receptor Antagonist Icotrokinra for Plaque Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Mohammed R. Abdeldayem, Ahmed Elsherbeeny

Journal of Cutaneous Medicine and Surgery